Total Payments
$1,083
2024 Payments
$208.84
Companies
15
Transactions
56
Medicare Patients
1,471
Medicare Billing
$84,862
Payment Breakdown by Category
Food & Beverage$1,033 (95.4%)
Education$50.23 (4.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,033 | 53 | 95.4% |
| Education | $50.23 | 3 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $444.61 | 22 | $0 (2024) |
| Astellas Pharma US Inc | $232.08 | 11 | $0 (2024) |
| Amgen Inc. | $86.08 | 5 | $0 (2021) |
| Organon Llc | $71.61 | 3 | $0 (2024) |
| PFIZER INC. | $53.92 | 3 | $0 (2023) |
| Merck Sharp & Dohme LLC | $33.42 | 2 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $25.76 | 2 | $0 (2018) |
| Radius Health, Inc. | $24.47 | 1 | $0 (2018) |
| Allergan Inc. | $18.49 | 1 | $0 (2018) |
| CooperSurgical, Inc. | $17.89 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $208.84 | 9 | Astellas Pharma US Inc ($118.92) |
| 2023 | $229.15 | 12 | AbbVie Inc. ($135.35) |
| 2022 | $279.02 | 14 | ABBVIE INC. ($206.89) |
| 2021 | $60.54 | 3 | AbbVie Inc. ($42.25) |
| 2020 | $73.80 | 4 | Amgen Inc. ($34.18) |
| 2019 | $77.83 | 5 | Amgen Inc. ($33.61) |
| 2018 | $131.75 | 8 | Astellas Pharma US Inc ($31.87) |
| 2017 | $22.09 | 1 | Astellas Pharma US Inc ($22.09) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Biological | ||||||
| 10/16/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: ETONOGESTREL | ||||||
| 09/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Biological | ||||||
| 08/01/2024 | Organon Llc | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 07/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Biological | ||||||
| 06/06/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: WOMENS HEALTH | ||||||
| 04/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Biological | ||||||
| 02/08/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: ETONOGESTREL | ||||||
| 01/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Biological | ||||||
| 12/08/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: WOMENS HEALTH | ||||||
| 11/28/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Biological | ||||||
| 10/24/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Biological | ||||||
| 10/10/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: WOMENS HEALTH | ||||||
| 08/25/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: WOMENS HEALTH | ||||||
| 07/11/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: WOMENS HEALTH | ||||||
| 06/22/2023 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: WOMENS HEALTH | ||||||
| 04/06/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: WOMENS HEALTH | ||||||
| 03/07/2023 | Baxter Healthcare | TISSEEL (Device) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Surgical Care | ||||||
| 02/09/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: WOMENS HEALTH | ||||||
| 02/07/2023 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 12/01/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: WOMENS HEALTH | ||||||
| 11/02/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: WOMENS HEALTH | ||||||
| 09/28/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: WOMENS HEALTH | ||||||
| 08/23/2022 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 367 | 367 | $85,314 | $21,003 |
| 2022 | 7 | 373 | 376 | $81,688 | $21,694 |
| 2021 | 6 | 428 | 431 | $92,216 | $25,088 |
| 2020 | 6 | 303 | 305 | $64,227 | $17,077 |
Total Patients
1,471
Total Services
1,479
Medicare Billing
$84,862
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 124 | 124 | $34,720 | $10,829 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 64 | $15,360 | $4,999 | 32.5% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 123 | 123 | $13,530 | $2,795 | 20.7% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 26 | 26 | $13,676 | $1,281 | 9.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 16 | 16 | $6,656 | $578.72 | 8.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 14 | 14 | $1,372 | $521.08 | 38.0% |
| 77067 | Screening mammography | Office | 2022 | 128 | 128 | $35,840 | $11,506 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 52 | $12,480 | $3,631 | 29.1% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 126 | 126 | $13,860 | $2,876 | 20.8% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 11 | 12 | $4,080 | $1,132 | 27.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 28 | 28 | $11,648 | $1,005 | 8.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 15 | $2,310 | $979.39 | 42.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 15 | 15 | $1,470 | $563.69 | 38.3% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 144 | 144 | $40,320 | $13,274 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 65 | $15,600 | $5,067 | 32.5% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 144 | 144 | $15,840 | $3,504 | 22.1% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 38 | 38 | $15,808 | $1,374 | 8.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 27 | 27 | $2,646 | $1,024 | 38.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 13 | $2,002 | $845.00 | 42.2% |
| 77067 | Mammography of both breasts | Office | 2020 | 94 | 94 | $26,320 | $8,880 | 33.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 55 | $13,137 | $3,465 | 26.4% |
| 77063 | Screening digital tomography of both breasts | Office | 2020 | 95 | 95 | $10,030 | $2,290 | 22.8% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 25 | 25 | $10,400 | $949.45 | 9.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 21 | 21 | $2,058 | $806.61 | 39.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 15 | $2,282 | $686.24 | 30.1% |
About Dr. Ryan Bannon, M.D
Dr. Ryan Bannon, M.D is a Obstetrics & Gynecology healthcare provider based in Wichita Falls, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104972496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Bannon, M.D has received a total of $1,083 in payments from pharmaceutical and medical device companies, with $208.84 received in 2024. These payments were reported across 56 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,033).
As a Medicare-enrolled provider, Bannon has provided services to 1,471 Medicare beneficiaries, totaling 1,479 services with total Medicare billing of $84,862. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Wichita Falls, TX
- Active Since 01/27/2007
- Last Updated 04/23/2015
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1104972496
Products in Payments
- LILETTA (Drug) $323.03
- Veozah (Drug) $164.48
- EVENITY (Biological) $86.08
- LO LOESTRIN FE (Drug) $69.43
- NEXPLANON (Drug) $55.69
- MYFEMBREE (Drug) $53.92
- ORIAHNN (Drug) $28.83
- VESICARE (Drug) $27.23
- JADA SYSTEM (Device) $27.15
- INTRAROSA (Drug) $25.76
- Tymlos (Biological) $24.47
- BRIDION (Drug) $22.19
- Myrbetriq (Drug) $22.09
- ORILISSA (Drug) $21.88
- Orilissa (Drug) $19.93
- MYRBETRIQ (Drug) $18.28
- Endosee (Device) $17.89
- CitraNatal (Drug) $17.74
- Balcoltra (Drug) $15.49
- SOLOSEC (Drug) $15.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Wichita Falls
Gradie Moore, M.d, M.D
Obstetrics & Gynecology — Payments: $2,914
Obstetrics & Gynecology $2,914
Dr. Jasbir Ahluwalia, M.d, M.D
Obstetrics & Gynecology — Payments: $2,568
Obstetrics & Gynecology $2,568
Dr. Steven Godfrey, M.d, M.D
Obstetrics & Gynecology — Payments: $2,483
Obstetrics & Gynecology $2,483
James Van Riper, D.o, D.O
Obstetrics & Gynecology — Payments: $2,096
Obstetrics & Gynecology $2,096
Dr. William Jones, M.d, M.D
Obstetrics & Gynecology — Payments: $1,953
Obstetrics & Gynecology $1,953
Mrs. Mandy Winfrey, M.d, M.D
Obstetrics & Gynecology — Payments: $961.26
Obstetrics & Gynecology $961.26